Admission Date:  [**2117-7-13**]       Discharge Date:  [**2117-9-23**]  Date of Birth:   [**2117-7-13**]       Sex:  M  Service:  NEONATOLOGY HISTORY OF PRESENT ILLNESS:  [**Known lastname **] [**Known lastname 9449**] baby boy number two was born at 27 and 6/7 weeks gestation to a 32 year-old gravida 1 para 0 now 2 woman by cesarean section.
The mother's prenatal screens are blood type O negative, antibody negative, Rubella immune, RPR nonreactive, hepatitis surface was achieved with invitro fertilization.
The pregnancy was complicated by preterm labor treated with magnesium sulfate.
The mother received a complete course of betamethasone completed actually on the day of delivery.
Respiratory status:  The infant was intubated at the time of admission to the Neonatal Intensive Care Unit and received two doses of Surfactant.
He weaned to nasopharyngeal continuous positive airway pressure on day of life seven and then weaned to nasal cannula oxygen on day of life forty six.
He was treated with caffeine citrate on day of life number three until day of life fifty three for apnea of prematurity.
Cardiovascular status:  [**Known lastname **] received a course of Indomethacin for a clinical presentation of a patent ductus arteriosus on day of life number one with resolution of his symptoms.
A cardiac echocardiogram at that time showed another patent ductus arteriosus and he received a second course of Indomethacin with resolution of his symptoms again.
Fluid, electrolytes and nutrition:  Enteral feeds were begun on day of life eleven.
Gastrointestinal status:  He was treated with phototherapy for physiologic hyperbilirubinemia on day of life number one until day of life number nineteen.
He was treated with Reglan and Zantac for gastroesophageal reflux on day of life forty seven until day of life sixty nine.
He has received no blood product transfusions during his Neonatal Intensive Care Unit stay.
Infectious disease status:  [**Known lastname **] was started on Ampicillin and Gentamycin at the time of admission for sepsis risk factors.
Antibiotics were discontinued after 48 hours and the blood cultures were negative and the infant was clinically well.
He was started on Oxacillin, Acyclovir and Erythromycin eye ointment.
He has remained off antibiotics since that time.
Feedings, the infant is eating 26 calories per ounce of breast milk made with 4 calories per ounce of Enfamil powder and 2 calories per ounce of corn oil on an ad lib schedule.
Medications, Fer-In-[**Male First Name (un) **] 0.3 cc to provide 7.5 mg of elemental iron po q.d.
Immunizations, the infant has received the following immunizations - hepatitis C vaccine on [**2117-9-11**], DtaP on [**2117-9-12**], HIB on [**2117-9-12**], IPV on [**2117-9-11**] and Prevnar on [**2117-9-13**].
Immunizations recommended - Synagis RSV prophylaxis should be considered from [**Month (only) 359**] through [**Month (only) 547**] for infants who meet any of the following three criteria, born at less then 32 weeks, born between 32 and 35 weeks with plans for day care during RSV season, with a smoker in the household or with preschool siblings or with chronic lung disease.
Influenza immunizations should be considered annually in the fall for preterm infants with chronic lung disease once they reach six months of age.
Before this age the family and other care givers to be considered for immunization against influenza to protect the infant.
Status post gastroesophageal reflux.
Status post patent ductus arteriosus times two.
